Related Experiment Video
Updated: Jul 20, 2025

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Causal relationships between obesity and pancreatobiliary diseases: a two-sample Mendelian randomization study
Dan Huang1, Yu Liu1, Wenjun Gong1
1Department of Clinical Pharmacy, The People's Hospital of Pengzhou, No. 255 Second section of South Third Ring Road, Chengdu, China.
General and abdominal obesity causally increase the risk of pancreatobiliary diseases. Weight loss is recommended to prevent these conditions, as indicated by body mass index (BMI) and waist circumference (WC) findings.
Area of Science:
- Gastroenterology and Hepatology
- Genetics and Epidemiology
Background:
- Observational studies suggest a link between obesity and pancreatobiliary diseases.
- Causality between obesity metrics and these diseases remains unconfirmed.
Purpose of the Study:
- To investigate the causal relationship between obesity indicators (BMI, WC, HC, WHR) and pancreatobiliary diseases using Mendelian Randomization.
- To provide evidence-based recommendations for disease prevention.
Main Methods:
- Two-Sample Mendelian Randomization (MR) analysis utilizing genome-wide association study (GWAS) data.
- Inverse variance weighted (IVW) method for causal effect estimation.
- Heterogeneity and pleiotropy assessed using Cochran's Q test, MR-Egger regression, and MR-PRESSO.
Main Results:
- A significant positive causal effect of body mass index (BMI) on pancreatobiliary diseases (OR: 1.021; P < 5x10^-15).
- A significant positive causal effect of waist circumference (WC) on pancreatobiliary diseases (OR: 1.021; P < 2x10^-10).
- No causal relationship found between hip circumference (HC), waist-to-hip ratio (WHR), and pancreatobiliary diseases.
Conclusions:
- General obesity (BMI) and abdominal obesity (WC) are causally linked to an increased risk of pancreatobiliary diseases.
- Interventions aimed at reducing BMI and WC may be effective in preventing these diseases.
- HC and WHR are not identified as causal risk factors in this analysis.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Obesity
Acute Pancreatitis II: Clinical Manifestations and Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

